13
Jan

Eli Lilly is buying big into the idea that the latest and greatest cancer therapies can work even better in combination, inking agreements to study its drugs alongside immunotherapies from Merck and Bristol-Myers Squibb.

…read more

Source: Lilly cuts in on immuno-oncology with Merck, Bristol-Myers

    

0 No comments